RPAM
Rhenman & Partners Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Sell |
65,755
-8,000
| -11% | -$407K | 0.42% | 62 |
|
|
2025
Q1 | $3.32M | Hold |
73,755
| – | – | 0.38% | 56 |
|
|
2024
Q4 | $3.05M | Sell |
73,755
-31,245
| -30% | -$1.29M | 0.31% | 69 |
|
|
2024
Q3 | $4.1M | Sell |
105,000
-29,250
| -22% | -$1.14M | 0.33% | 70 |
|
|
2024
Q2 | $4.59M | Buy |
134,250
+42,000
| +46% | +$1.44M | 0.44% | 57 |
|
|
2024
Q1 | $2.32M | Buy |
+92,250
| New | +$2.32M | 0.22% | 72 |
|